A high volume of PCR testing is peformed in China, with thousands of hospital labs performing tests. From 2000 to 2004, the PCR market in China nearly doubled. Growth rate has moderated substantially to 10-15% in the last couple of years. Those watching the Chinese IVD markets will find this to be a critical resource with the following information:
A Review of Developments in Chinese IVD
Markets for Molecular Diagnostics in China
Instrument and Reagent Segments
Government Activity Related to PCR Testing
Market Share of Major Players
Company Profiles
Table of Contents
TABLE OF CONTENTS
CHAPTER ONE: EXECUTIVE SUMMARY
What’s New in China
Molecular Diagnostics in China
Company Profiles
A Note on Names and Spelling
Abbreviations Used in This Report
CHAPTER TWO: COUNTRY SUMMARY
What’s New in China
The Healthcare System in China
Privatization
Private and Reference Laboratories
Private Medical Practice
Medical Insurance
A Brief Guide to the Bureaucracy
Product Registration
The “Clean” Campaign
Reimbursement
Tenders
Reagent Rental
Quality Control
Vacuum Tube Conversion
Consolidated Work Stations and Sample Automation
Second-hand Instruments
CHAPTER THREE: MARKET ANALYSIS
Commentary
Market Leaders
Pricing and Reimbursement
Quality Issues
Other Molecular Products
International Companies
CHAPTER FOUR: COMPANY PROFILES
Abbott Laboratories
Applied Biosystems
Amplly
Bioer Technology
Bio-Hema
BioMérieux (France)
Bayer HealthCare (US)
Da An Gene
Elikan Biological Technology
Fosun Diagnostics
Gene Company
Haoyuan Biotechnology
HealthDigit
Intec Products
Kehua Biotech
Lengguang Technology
Promega (US)
PG (PiGi)
Qiagen
Roche
Sciarray Biotech
Science International/Science Laboratories
Sino-American Biotechnology Company
TABLE OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
Exhibit 1: Chinese IVD Market, 1996-2006
Exhibit 2: Chinese Molecular Diagnostics Market, 2006
CHAPTER TWO: COUNTRY SUMMARY
Exhibit 3: Hospitals in China by Level (Level I, II, III, A, B, C and Unrated)
Exhibit 4 Hospitals in China by Number of Beds
CHAPTER THREE: MARKET ANALYSIS
Exhibit 6: Reagent Sales in China (Infectious Disease, Other)
Exhibit 7: Instrument Sales in China (Units Placed, Units Rented, Units Sold, Average Price)
Exhibit 8: Molecular Diagnostics in China
Exhibit 9: Reagent Market in China by Category (Kinetic/QPCR, Traditional, Other)
Exhibit 10: Instruments in China by Category (End Point, Kinetic)
Exhibit 11: Market Leaders
Exhibit 12: Average Price Lists for PCR Tests
Exhibit 13: Key Analytes (Analyte, Market Share)
Exhibit 14: Reimbursement Range for Kinetic Molecular Testing
Exhibit 15: Molecular Testing Distribution Companies
If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.